Trade Celularity Inc. - CELU CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.1034 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.6933 |
| Open | 1.6433 |
| 1-Year Change | -67.77% |
| Day's Range | 1.6433 - 1.7933 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1.6933 | -0.1000 | -5.58% | 1.7933 | 1.7933 | 1.6533 |
| Mar 28, 2025 | 1.7633 | -0.1100 | -5.87% | 1.8733 | 1.9333 | 1.7433 |
| Mar 27, 2025 | 1.8733 | -0.1100 | -5.55% | 1.9833 | 1.9933 | 1.8333 |
| Mar 26, 2025 | 1.9933 | -0.0200 | -0.99% | 2.0133 | 2.0533 | 1.8633 |
| Mar 25, 2025 | 2.0733 | 0.2600 | 14.34% | 1.8133 | 2.3233 | 1.8133 |
| Mar 24, 2025 | 1.8333 | 0.0800 | 4.56% | 1.7533 | 1.8533 | 1.7533 |
| Mar 21, 2025 | 1.7933 | 0.1500 | 9.13% | 1.6433 | 1.8233 | 1.6433 |
| Mar 20, 2025 | 1.6433 | 0.0500 | 3.14% | 1.5933 | 1.7133 | 1.5933 |
| Mar 19, 2025 | 1.6433 | 0.0300 | 1.86% | 1.6133 | 1.7333 | 1.5433 |
| Mar 18, 2025 | 1.5333 | 0.0500 | 3.37% | 1.4833 | 1.5733 | 1.4833 |
| Mar 17, 2025 | 1.4833 | 0.0300 | 2.06% | 1.4533 | 1.5333 | 1.4433 |
| Mar 14, 2025 | 1.5333 | 0.0300 | 2.00% | 1.5033 | 1.5633 | 1.5033 |
| Mar 13, 2025 | 1.5133 | -0.1300 | -7.91% | 1.6433 | 1.6433 | 1.3933 |
| Mar 12, 2025 | 1.5533 | 0.2500 | 19.18% | 1.3033 | 1.5933 | 1.2833 |
| Mar 11, 2025 | 1.2833 | -0.0200 | -1.53% | 1.3033 | 1.3233 | 1.2433 |
| Mar 10, 2025 | 1.3033 | 0.1100 | 9.22% | 1.1933 | 1.3133 | 1.1333 |
| Mar 7, 2025 | 1.2033 | -0.1100 | -8.38% | 1.3133 | 1.3233 | 1.1933 |
| Mar 6, 2025 | 1.2833 | -0.0100 | -0.77% | 1.2933 | 1.3833 | 1.2333 |
| Mar 5, 2025 | 1.3433 | 0.1500 | 12.57% | 1.1933 | 1.6133 | 1.1333 |
| Mar 4, 2025 | 1.0533 | -0.0500 | -4.53% | 1.1033 | 1.1933 | 0.9933 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Celularity Inc. Company profile
About Celularity Inc
Celularity Inc. is a clinical-stage biotechnology company. The Company is engaged in developing off-the-shelf placental-derived allogeneic T cells engineered with a chimeric antigen receptor (CAR) (CAR-T) cells, natural killer (NK) cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, infectious and degenerative diseases. It has four placental-derived allogeneic cell types: T cells, unmodified NK cells, genetically modified NK cells and ASCs, which resulted in four key cell therapeutic programs: CyCART-19, CYNK-001, CYNK-101 and APPL-001, focused on six initial indications. Its CyCART-19 is a placental-derived CAR-T cell therapy, in development for the treatment of B-cell malignancies, initially targeting the CD19 receptor. CYNK-001 is developing for the treatment of acute myeloid leukemia (AML), a blood cancer, and for glioblastoma multiforme (GBM), a solid tumor cancer, and COVID-19.
Financial summary
BRIEF: For the six months ended 30 June 2021, Celularity Inc revenues was not reported. Net income totaled $30.9M vs. loss of $5.7M. Net income reflects Change in fair value of warrant liabilit increase from $6.6M (expense) to $34.5M (income), Unrealized gain on marketable securities decrease from $42K (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.16 to $0.70.
| Industry: | Bio Therapeutic Drugs |
170 Park Ave
FLORHAM PARK
NEW JERSEY 07932
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com